Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
Recruiting now
Conditions studied: Dilated Cardiomyopathy (DCM)
In brief
The goal of this observational study is to learn about the long-term prognostic of coronary microvascular dysfuction in Patients with Dilated Cardiomyopathy. The main question it aims to answer is: Does the coronary microvascular dysfunction impact the outcomes in Patients with Dilated Cardiomyopathy.
Key facts
- Study ID
- NCT07293338
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- People needed
- 330
- Starts
- 2026-01-06
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Dilated cardiomyopathy comfirmed by echocardiography: LVDd > 55 mm in men or > 50 mm in women.
- Clinically evident congestive heart failure: Compatible symptoms and signs, and BNP ≥ 35 pg/mL or NT-proBNP ≥ 125 pg/mL, and LV systolic dysfunction defined by LVEF < 45 %.
- Coronary angiography showing stenosis ≤ 50 % in all major epicardial vessels.
You may not qualify if…
- Patients with coronary artery disease, hypertensive heart disease, rheumatic valvular heart disease, myocarditis, and other secondary cardiomyopathies.
- poor angiographic image quality
Where it is running
- The second affiliated hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.